Epithelial miR‐215 negatively modulates Th17‐dominant inflammation by inhibiting CXCL12 production in the small intestine
Genes to Cells · 2022-04 · 27 (4) · 243-253
DOI: 10.1111/gtc.12922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 06.02.2022. Verfasst von Siddhika Pareek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Inflammation, Intestine, Small, MicroRNAs, Th17 Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology of Japan, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
MicroRNAs are a class of non‐coding short‐chained RNAs that control cellular functions by downregulating their target genes. Recent research indicates that microRNAs play a role in the maintenance of gut homeostasis. miR‐215 was found to be highly expressed in epithelial cells of the small intestine; however, the involvement of miR‐215 in gut immunity remains unknown. Here, we show that miR‐215 negatively regulates inflammation in the small intestine by inhibiting CXCL12 production. Mice lacking miR‐215 showed high susceptibility to inflammation induced by indomethacin, accompanied by an increased number of Th17 cells in the lamina propria of the small intestine. Our findings provide a rationale for targeting miR‐215 as a therapeutic intervention for inflammatory conditions in the small intestine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
- Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
- Institute for Advanced Co-Creation Studies, Osaka University, Osaka, Japan.
- Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
ORCID-Profile: Kiyoshi Takeda
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
- Japan Agency for Medical Research and Development
Zitieren
APA
Pareek, S., Sanchenkova, X., Sakaguchi, T., Murakami, M., Okumura, R., Kayama, H., Kawauchi, S., Motooka, D., Nakamura, S., Okuzaki, D., Kishimoto, T., & Takeda, K. (2022). Epithelial miR‐215 negatively modulates Th17‐dominant inflammation by inhibiting CXCL12 production in the small intestine. Genes to Cells, 27(4), 243-253. https://doi.org/10.1111/gtc.12922
Vancouver
Pareek S, Sanchenkova X, Sakaguchi T, Murakami M, Okumura R, Kayama H, et al. Epithelial miR‐215 negatively modulates Th17‐dominant inflammation by inhibiting CXCL12 production in the small intestine. Genes to Cells. 2022;27(4):243-253. doi:10.1111/gtc.12922
BibTeX
@article{Pareek2022,
author = {Pareek, Siddhika and Sanchenkova, Xenia and Sakaguchi, Taiki and Murakami, Mari and Okumura, Ryu and Kayama, Hisako and Kawauchi, Saya and Motooka, Daisuke and Nakamura, Shota and Okuzaki, Daisuke and Kishimoto, Tadamitsu and Takeda, Kiyoshi},
title = {Epithelial miR‐215 negatively modulates Th17‐dominant inflammation by inhibiting CXCL12 production in the small intestine},
journal = {Genes to Cells},
year = {2022},
volume = {27},
number = {4},
pages = {243--253},
doi = {10.1111/gtc.12922}
}
EUVIMED